Two control cohorts with wildtype TP53 were used for comparison: (i) whole-exome data from the 1000 Genomes Project (1kGP) consisting of cancer-free individuals (n = 2,504) and (ii) whole-genome data from the KiCS Project consisting of individuals with no known cancer predisposition disorder, who developed cancer (n = 185). Here, TP53 is linked to cancer.